The 10% Lidocaine spray produced and marketed by EGIS has the following routine fields of indications: in ENT surgery and dentistry, superficial minor surgical interventions, and the introduction of anaesthesia by injection. The 5% Lidocaine ointment has been routinely used in the treatment of chronic locomotor diseases, traumatological and surgical conditions, and in painful skin and mucous membrane ulcers and erosions accompanied by epithelial deficiency.